1. Clinical implications and cost-effectiveness analysis of rivaroxaban in patients with coronary artery disease or peripheral arterial disease in the Netherlands. (1st January 2021) Authors: Spoorendonk, J. A.; Briere, J.-B.; Bowrin, K.; Millier, A.; Coppens, M.; Tempelaar, S.; Verheggen, B. Journal: Journal of medical economics Issue: Volume 24:Number 1(2021) Page Start: 1231 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗